Xu et al., 2006 - Google Patents
Preparation and determination of immunological activities of anti-HBV egg yolk extractionXu et al., 2006
View PDF- Document ID
- 4995206409734723147
- Author
- Xu Y
- Zou W
- Zhan X
- Yang S
- Xie D
- Peng S
- Publication year
- Publication venue
- Cell Mol Immunol
External Links
Snippet
To prepare an effective immune preparation to treat hepatitis B, hens were immunized with hepatitis B vaccines, and then anti-HBV egg yolk extraction (anti-HBV EYE) was refined from egg yolk by a dialyzable method. Its chemical characteristics were identified by ultraviolet …
- 210000002969 Egg Yolk 0 title abstract description 27
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rivera et al. | Ginseng and aluminium hydroxide act synergistically as vaccine adjuvants | |
| WO2023116374A1 (en) | Herpes zoster vaccine composition | |
| KR102254955B1 (en) | Viral Immunotherapy Drug Complex and Uses Thereof | |
| Xu et al. | Preparation and determination of immunological activities of anti-HBV egg yolk extraction | |
| Guo et al. | Immunoregulatory effects of Taishan Pinus massoniana pollen polysaccharide on chicks co-infected with avian leukosis virus and Bordetella avium early in ovo | |
| CN103561763A (en) | Immunogenic bordetella bronchiseptica compositions | |
| Al-Shammari et al. | Immunology study for NDV treatment in mice bearing mammary adenocarcinoma tumor | |
| US20200261570A1 (en) | Immunopotentiator, foot-and-mouth disease inactivated vaccine and preparation method thereof | |
| CN104258381B (en) | Ovarian cancer stem cell vaccine and preparation method and application | |
| CN105456185A (en) | Compound Astragalus polysaccharides injection and preparation method thereof | |
| CN107693788B (en) | Pharmaceutical composition for preventing or treating hepatitis B and application thereof | |
| CN113181349B (en) | M cell-targeted multi-epitope oral vaccine and application thereof in hydatid vaccine | |
| CN103547286B (en) | A kind of composition of DNA vaccine for preventing and treat hepatitis B | |
| CN101838325B (en) | Antigen-presenting protein for swines and encoding gene and application thereof | |
| CN104587463B (en) | Activating effect and its application of the fish NKEF A recombinant proteins to adaptability humoral immunity | |
| CN102813920A (en) | Vaccine adjuvant | |
| CN103272240B (en) | Composite heat protectant for specific transfer factor of nephropathogenic infectious bronchitis, and application thereof | |
| CN102499983A (en) | Application of HepG2.2.15 cell autophagy corpuscle in preparing hepatitis b virus (HBV) therapeutic vaccines | |
| CN101759770A (en) | Method for extracting transfer factor from chicken spleen | |
| CN1990043B (en) | Use of recombinant human granulocyte macrophagocyte colony stimulating factor in preparation of drug for preventing and treating hepatitis B | |
| CN105497890A (en) | Application of alpine yarrow herb polysaccharide as vaccine adjuvant | |
| CN101289653A (en) | Nicotine-processed dendritic cells for preventing and treating tumors | |
| CN105820228A (en) | H-2d restricted Th epitope P2 of trichina paramyosin, its composition and application thereof | |
| WO2024114650A1 (en) | Recombinant herpes zoster vaccine and preparation therefor and use thereof | |
| CN1326567C (en) | Egg yolk antibody composition for preventing and treating atypical pneumonia and its preparation method |